ASTH

Astrana Health, Inc. (ASTH) SWOT Analysis Analysis (2026)

Invetso Score: 4.8/10 — Balanced · Last Updated: 2026-08-01

Strengths

ROIC of 4.1% indicates modest capital efficiency, but it remains below stronger specialty peers that typically sustain higher returns through better pricing power.

A cash conversion cycle of 21 days supports working-capital discipline, which is structurally better than peers with longer inventory and receivables cycles.

The balance sheet shows liquidity coverage above 1.2x, helping ASTH avoid near-term funding stress relative to weaker peers with tighter current ratios.

Weaknesses

Net debt to EBITDA of 3.0x leaves ASTH more leveraged than many peers, constraining strategic flexibility and amplifying earnings sensitivity to margin pressure.

Debt to equity of 1.18x indicates a meaningfully levered capital structure, which is less resilient than lower-geared peers in a higher-rate environment.

Current and quick ratios of 1.23x are only adequate, leaving less liquidity headroom than stronger peers that can absorb working-capital shocks more easily.

Opportunities

If ASTH improves operating efficiency, its modest ROIC base leaves room for peer-relative gains through better asset utilization and pricing discipline.

Further working-capital optimization could extend its already favorable cash conversion cycle, strengthening free-cash-flow conversion versus peers with slower collections.

Deleveraging would improve competitive positioning by lowering interest burden and increasing capacity to invest versus more constrained peers.

Threats

Higher leverage increases vulnerability to earnings volatility, making ASTH more exposed than peers if demand softens or reimbursement pressure intensifies.

With only moderate liquidity, any working-capital disruption could force more expensive financing than better-capitalized peers can avoid.

Subpar return generation versus stronger peers raises the risk that capital remains tied up without producing comparable long-term competitive advantage.

Overall Score

ASTH’s structural position is mixed, with acceptable working-capital discipline offset by weaker leverage and only modest return generation versus peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Astrana Health, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →